Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 10.58%
- Poor long term growth as Net Sales has grown by an annual rate of 38.89% and Operating profit at 18.10% over the last 5 years
- The company is Net-Debt Free
2
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-21.39%
0%
-21.39%
6 Months
-13.71%
0%
-13.71%
1 Year
-16.6%
0%
-16.6%
2 Years
83.02%
0%
83.02%
3 Years
33.7%
0%
33.7%
4 Years
-0.73%
0%
-0.73%
5 Years
-55.38%
0%
-55.38%
Seach Medical Group Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
38.89%
EBIT Growth (5y)
18.10%
EBIT to Interest (avg)
3.12
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.17
Sales to Capital Employed (avg)
1.73
Tax Ratio
6.02%
Dividend Payout Ratio
391.30%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
10.58%
ROE (avg)
4.64%
Valuation key factors
Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
0.95
EV to EBIT
3.85
EV to EBITDA
3.05
EV to Capital Employed
0.93
EV to Sales
0.36
PEG Ratio
NA
Dividend Yield
0.40%
ROCE (Latest)
24.08%
ROE (Latest)
8.99%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
39.00
39.00
Operating Profit (PBDIT) excl Other Income
5.20
2.60
100.00%
Interest
0.40
0.50
-20.00%
Exceptional Items
0.20
-0.20
200.00%
Consolidate Net Profit
5.40
1.20
350.00%
Operating Profit Margin (Excl OI)
106.20%
39.40%
6.68%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is 0.00% vs -6.25% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is 350.00% vs 0.00% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
157.20
171.70
-8.44%
Operating Profit (PBDIT) excl Other Income
18.10
19.40
-6.70%
Interest
1.80
2.30
-21.74%
Exceptional Items
-0.60
4.10
-114.63%
Consolidate Net Profit
0.40
13.60
-97.06%
Operating Profit Margin (Excl OI)
89.50%
84.10%
0.54%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -8.44% vs 14.24% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -97.06% vs 214.29% in Dec 2024






